glp 1 medications for obesity Anti-obesity drugs are closing the gap between dieting and bariatric surgery | Diet and Nutrition | Prevention New GLP-1 Pill Foundayo (Orforglipron)

To attain these health benefits, however, it is critical that people prescribed GLP-1s continue to take them at least long enough to realize clinical success, and preferably longer to avoid possible weight rebound once they come off the medications

This indicates that orforglipron could become available to consumers following regulatory approval

In jurisdictions where it is approved, phentermine topiramate is typically indicated for adults with a body mass index (BMI) of 30 kg/m or greater , or those with a BMI of 27 kg/m or greater in the presence of at least one weight-related comorbidity such as type 2 diabetes, hypertension, or dyslipidaemia

A healthy gut microbiome is essential to stimulate GLP-1 release